Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Teva bags HY debut success giving buyers rare premium
Teva Pharmaceutical's $5 Billion Sustainability-Linked Bond Offering – Global Legal Chronicle
Credit Line and Bonds: Teva's Financial Catch | Ctech
Teva Sells $15 Billion of Bonds - WSJ
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Moody's Downgrades Teva Bond Rating to “Junk” | Ctech
Jot van Suijlen – Global Legal Chronicle
Why did Teva fall 20% in April-May? - Globes
Representing TEVA on Issuance of USD 2.49 Billion - Agmon and Tulchinsky
Solved As an investor, you have $13,800 in Teva Pharma with | Chegg.com
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Ltd. – Artonpapers
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva lining up alone in EM bonds
Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes | Business Wire
Sold 1 Put Option on TEVA Stock – 4.10% potential income return in 63 days (23.73% annualized)
Alvotech Expands Biosimilar Collaboration with Teva Amid Manufacturing Woes | BioSpace
S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable
Teva Pharmaceuticals on Twitter: "Teva announces new ESG targets addressing two of today's greatest global crises, access to medicines and climate change. Targets are tied to our recent issuance of a $5
